Atlas Trials

Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors

Clinical trial NCT02870036 · UNKNOWN

Trial details

NCT number
NCT02870036
Sponsor
Haihe Biopharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorAdvanced/Metastatic Colorectal Cancer
Start date
2016-10-01
Primary completion
2020-12-01
Enrollment
243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.